These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23572517)

  • 1. Metabolite profiling to characterize disease-related bacteria: gluconate excretion by Pseudomonas aeruginosa mutants and clinical isolates from cystic fibrosis patients.
    Behrends V; Bell TJ; Liebeke M; Cordes-Blauert A; Ashraf SN; Nair C; Zlosnik JE; Williams HD; Bundy JG
    J Biol Chem; 2013 May; 288(21):15098-109. PubMed ID: 23572517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.
    Mahenthiralingam E; Campbell ME; Foster J; Lam JS; Speert DP
    J Clin Microbiol; 1996 May; 34(5):1129-35. PubMed ID: 8727889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.
    Hoffman LR; Richardson AR; Houston LS; Kulasekara HD; Martens-Habbena W; Klausen M; Burns JL; Stahl DA; Hassett DJ; Fang FC; Miller SI
    PLoS Pathog; 2010 Jan; 6(1):e1000712. PubMed ID: 20072604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensor kinase CbrA is a global regulator that modulates metabolism, virulence, and antibiotic resistance in Pseudomonas aeruginosa.
    Yeung AT; Bains M; Hancock RE
    J Bacteriol; 2011 Feb; 193(4):918-31. PubMed ID: 21169488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy
    McLean K; Lee D; Holmes EA; Penewit K; Waalkes A; Ren M; Lee SA; Gasper J; Manoil C; Salipante SJ
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.
    Gifford AH; Willger SD; Dolben EL; Moulton LA; Dorman DB; Bean H; Hill JE; Hampton TH; Ashare A; Hogan DA
    Infect Immun; 2016 Oct; 84(10):2995-3006. PubMed ID: 27481238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
    Xia Y; Wang D; Pan X; Xia B; Weng Y; Long Y; Ren H; Zhou J; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking RpoN reduces virulence of Pseudomonas aeruginosa isolated from cystic fibrosis patients and increases antibiotic sensitivity in a laboratory strain.
    Lloyd MG; Vossler JL; Nomura CT; Moffat JF
    Sci Rep; 2019 Apr; 9(1):6677. PubMed ID: 31040330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
    Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF
    Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
    Gutu AD; Sgambati N; Strasbourger P; Brannon MK; Jacobs MA; Haugen E; Kaul RK; Johansen HK; Høiby N; Moskowitz SM
    Antimicrob Agents Chemother; 2013 May; 57(5):2204-15. PubMed ID: 23459479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections.
    Behrends V; Ryall B; Zlosnik JE; Speert DP; Bundy JG; Williams HD
    Environ Microbiol; 2013 Feb; 15(2):398-408. PubMed ID: 22882524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of metabolic profiles of cystic fibrosis Pseudomonas aeruginosa during the early stages of lung infection.
    Jørgensen KM; Wassermann T; Johansen HK; Christiansen LE; Molin S; Høiby N; Ciofu O
    Microbiology (Reading); 2015 Jul; 161(7):1447-62. PubMed ID: 25873584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiling of Pseudomonas aeruginosa demonstrates that the anti-sigma factor MucA modulates osmotic stress tolerance.
    Behrends V; Ryall B; Wang X; Bundy JG; Williams HD
    Mol Biosyst; 2010 Mar; 6(3):562-9. PubMed ID: 20174684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of polyhydroxyalkanoate biosynthesis in Pseudomonas putida and Pseudomonas aeruginosa.
    Hoffmann N; Rehm BH
    FEMS Microbiol Lett; 2004 Aug; 237(1):1-7. PubMed ID: 15268931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.
    Hoffman LR; Kulasekara HD; Emerson J; Houston LS; Burns JL; Ramsey BW; Miller SI
    J Cyst Fibros; 2009 Jan; 8(1):66-70. PubMed ID: 18974024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the Crc regulator on the hierarchical use of carbon sources from a complete medium in Pseudomonas.
    La Rosa R; Behrends V; Williams HD; Bundy JG; Rojo F
    Environ Microbiol; 2016 Mar; 18(3):807-18. PubMed ID: 26568055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RpoN-Dependent Direct Regulation of Quorum Sensing and the Type VI Secretion System in Pseudomonas aeruginosa PAO1.
    Shao X; Zhang X; Zhang Y; Zhu M; Yang P; Yuan J; Xie Y; Zhou T; Wang W; Chen S; Liang H; Deng X
    J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29760208
    [No Abstract]   [Full Text] [Related]  

  • 18. The anti-sigma factor MucA is required for viability in Pseudomonas aeruginosa.
    Schofield MC; Rodriguez DQ; Kidman AA; Cassin EK; Michaels LA; Campbell EA; Jorth PA; Tseng BS
    Mol Microbiol; 2021 Aug; 116(2):550-563. PubMed ID: 33905139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.